LOUISVILLE, Ky., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per common share. The dividend will be paid on April 1, 2026, to stockholders of record as of March 16, 2026. Louisville, Kentuck ...

2025 Net Income of $35.4 million, EBITDA1 of $89.8 million and Free Cash Flow to Equity1 of $37.1 million18th Quarterly Dividend of Cdn$0.04 Declared$20.4 million Returned to Shareholders in 2025Company Remains Bullish on Copper Prices, Capital Return Strategy Fully Deployed VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce strong financial results for the year and three months (“Q4-2025”) ended ...

SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (“Serve”) (Nasdaq: SERV), a leading autonomous robotics company, today announced that it will report its 2025 fourth quarter financial results before the opening of regular trading on Wednesday, March 11, 2026. The company will host a conference call and webcast to review the results on the same day. Conference Call and Webcast InformationCompany management will host a conference call at 8 a.m. PT / 11 a.m. ET. A live audio webcast will be ...

CELEBRATION, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the Citizens Life Sciences Conference in Miami Beach, FL on Wednesday, March 11, 2026, at 9:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link ...

VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is pleased to announce a non-brokered private placement financing for gross proceeds of up to $3,000,000 (the “Offering”). Under the Offering, subject to regulatory approval, the Company intends to issue up to 8,571,429 units (the “Units”) at a price of $0.35 per Unit. Each Unit will consist of one common share of the Company and one-half (1/2) of one common share purchase ...

Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOB ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the following upcoming investor conferences: TD Cowen 46th Annual Health Care Conference, fireside chat on Wednesday, March 4, 2026 at 11:50 a.m. ET in Boston, MA2026 Jefferies Biotech on the Beach Summit, hosting meetings o ...

Core Insights - Digital Realty is expanding its Digital Realty Innovation Lab (DRIL) into Singapore, Japan, and London, marking its first foray into Asia Pacific and Europe after a successful launch in Northern Virginia [1][2] - The new DRIL locations will provide real-world testing environments for customers and partners to validate AI and hybrid cloud deployments, addressing the critical barrier of infrastructure readiness as AI adoption increases [2][7] Expansion Details - The Singapore DRIL will serve as a digital innovation hub, connecting local customers, partners, and research institutions with global technology providers [4] - The Japan DRIL will be located at the NRT12 data center in Greater Tokyo, featuring 20 racks with direct liquid cooling capabilities to support high-power-density workloads [5] - The UK DRIL in London will offer a dedicated environment for testing and validating AI and hybrid cloud deployments before full-scale implementation [5] Market Context - Singapore's digital economy, driven by AI adoption, accounts for 18.6% of total GDP, while Japan plans to invest over 10 trillion yen in semiconductor and AI sectors by 2030 [3] - The UK's AI sector is growing rapidly, with over 5,800 AI companies and sector revenue reaching £23.9 billion, generating £11.8 billion in GVA [3] Infrastructure Capabilities - The new DRIL locations will enable businesses to test performance, optimize configurations, and connect seamlessly to cloud and network providers via ServiceFabric®, Digital Realty's global interconnection platform [8] - The DRIL will leverage Digital Realty's Pervasive Datacenter Architecture (PDx®) methodology to facilitate the testing and validation of AI deployments in real-world conditions [9][10] Customer Engagement - Strong demand has been observed from customers and partners across Asia Pacific for dedicated environments to validate AI and hybrid cloud architectures [7] - The DRIL network supports a growing ecosystem of customers and partners, including major technology firms like AMD, Cisco, and Lenovo [10]

SPOKANE, Wash., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today reported net income based on GAAP of $193 million, or $2.38 per diluted share, compared to $180 million, or $2.29 per diluted share, in 2024. Non-GAAP utility earnings1 were $207 million, or $2.55 per diluted share, compared to $187 million, or $2.38 per diluted share in 2024. Our utility results were driven by strong operational execution, constructive regulatory outcomes, customer load growth, and disciplined cost management. ...

Enrollment completed six months ahead of guidance, driven by significant unmet need for better treatments in CSUTopline data expected Q4 2026BLA submission planned for 2027 HAMPTON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today the completion of enrollment in the Company’s global Phase 3 program of barzolvolimab in chronic spontaneous urticaria (CSU), which consists of two Phase 3 trials—EMBARQ-CSU1 and EMBARQ-CSU2. 1,939 patients were enrolled—the largest program conducted i ...